This process allowed for a precise spatiotemporal codelivery of antibodies to simultaneously block T-cell inhibition by PD-1 antibodies and upregulate T-cell activity by OX40 antibodies while significantly increasing the number of CD8+ T cells infiltrating the tumor site compared to codelivery of free antibodies 78. The gene discussed is PDCD1; the disease is neoplasm.